Table 3. Exosome-Based Clinical Trial in Ovarian Cancer.
| Trail ID | Status | Timeline | Core study | Clinical impact | Funding |
|---|---|---|---|---|---|
| NCT03738319 | Unknowna | 2018–2019 | Sequencing of miRNA/lncRNA | Study based on noncoding RNA of exosome, role in epithelial ovarian cancer and diagnosis, and prognosis marker development | Professor Lei Li, Peking Union Medical College Hospital, China |
| NCT02063464 | Completed | 2014–2016 | Ovarian cancer ovarian, epithelial, and fallopian tube cancer patients’ blood | Monocytes’ anticancer activity and exosome interlink | NIH, USA |
| NCT02662621 | Completed | 2015–2019 | Isolation of exosomes from blood and urine | Exosome HSP70 protein role in ovarian cancer and earlier detection of the biomarker of ovarian cancer | Centre Georges Francois Leclerc, France |
a
The study has passed its completion date, and the status has not been verified in more than two years (source: https://clinicaltrials.gov/).